Human T-lymphotropic virus 1

Lore & Background

HTLV-1 was first identified through studies of adult T-cell lymphoma (ATL), which was described in 1977 in a case series from Japan. The clustering of cases by birthplace suggested an infectious cause, initially called ATLV. The virus was independently and concurrently discovered by two teams: Bernard Poiesz, Francis Ruscetti, and colleagues in Robert C. Gallo's laboratory at the National Cancer Institute, and a Japanese team led by Yorio Hinuma, who identified ATLV. Later studies proved ATLV identical to HTLV-1, and the virus is now generally called HTLV-1.

HTLV-1 is a deltaretrovirus with a positive-sense RNA genome that is reverse transcribed and integrated into host DNA. It spreads cell-to-cell via a viral synapse, with few free virions produced. It predominantly infects CD4+ T cells but can also be found in CD8+ T cells, dendritic cells, and B cells. Entry is mediated by the viral envelope glycoprotein interacting with the GLUT1 glucose transporter.

The virus is believed to have originated from simian T-lymphotropic virus type 1 (STLV-1) through zoonotic transmissions from nonhuman primates in Africa. Seven subtypes exist, with cosmopolitan subtype A being most widespread. Prevalence increases with age and is generally higher in adult females than males.

Reader's Guide

HTLV-1 is significant as the first identified human retrovirus and as a cause of two severe diseases: adult T-cell lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Most infected individuals remain asymptomatic, but lifetime risks are about 5% for ATL and 2% for HAM/TSP. The virus is transmitted vertically through breastfeeding, sexually (with male-to-female transmission more efficient), and parenterally via blood transfusion or needle sharing. Geographic clustering varies: Japan shows mother-to-child transmission dominance, while the Caribbean shows more sexual transmission. Global prevalence is likely underestimated due to lack of data from populous regions like India and Nigeria. In Central Australia, prevalence exceeds 30% among Aboriginal communities, the highest reported worldwide. The virus's ability to integrate as a provirus ensures lifelong infection, and diagnosis relies on detecting antibodies in serum. Understanding HTLV-1 has informed retrovirus biology and highlighted the role of zoonotic origins in human disease.

Did You Know?

• HTLV-1 was the first human retrovirus discovered, identified independently and concurrently by Bernard Poiesz, Francis Ruscetti, and colleagues in Robert C. Gallo's laboratory, and by a Japanese team led by Yorio Hinuma.
• The estimated lifetime risk of adult T-cell lymphoma among infected individuals is about 5%, and for HAM/TSP about 2%.
• In Central Australia, HTLV-1 prevalence exceeds 30% among Aboriginal communities, the highest reported for any population worldwide.